Updated:
Zymo Research
Zymo Research is a global biotech tools and services company founded in 1994, providing epigenetics, microbiome, and NGS kits to life science researchers.
Zymo Research
Zymo Research was founded in 1994 by a founder whose identity is not publicly disclosed. The company started in a garage in Orange, California, and has since expanded to include international facilities. Wealth origin is undisclosed, and the firm presents as a private company without external capital reported. The company sells molecular biology products across several categories: sample collection (DNA/RNA Shield), nucleic acid purification (Quick-DNA, Direct-zol RNA kits), epigenetics (bisulfite conversion kits for DNA methylation analysis), and microbiology standards (ZymoBIOMICS Microbial Community Standard). It also provides NGS services including microbiome sequencing, RNA-Seq, and DNA methylation analysis. Product lines are marketed to research labs, public health agencies, and clinical diagnostics. The firm participates in wastewater surveillance programs. Confirmed geographies include North America and Europe, with a global distributor network. No total deployment, AUM, or number of professionals is disclosed. Additional offices include Fort Collins, Colorado. The firm operates a grant program: the 2025 RNome Disruptive Research Grant and the 2026 Fecal Microbiome Discovery Grant announced in April 2026 (per firm website, April 2026). There is no disclosed family office structure, philanthropic foundation, or adjacent vehicle. The structural differentiator is that Zymo Research is a private life-sciences product and service company, not a capital allocator. It has no disclosed asset management or investment operation, making its classification as a family office or asset manager unsupported by available information.
General information
Firm type
Asset Manager
Year founded
1994
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Irvine
Corporate office
Irvine, CA, United States
Additional offices
Fort Collins, CO, United States
Frequently asked questions
Who funds Zymo Research?
Zymo Research is a privately held company. No external investors or parent firm ownership is disclosed. The company has not reported raising capital from venture or private equity sources.
Does Zymo Research operate as a family office?
There is no public evidence that Zymo Research functions as a family office, single or multi-family. It appears to operate solely as a life sciences products and services business. No investment arm or capital allocation activity is described.
What investment stages or asset classes does Zymo Research target?
Zymo Research does not publicly report any investment activity. It is a molecular biology tool company selling kits and services for genomics and microbiomics. There are no disclosed fund commitments, direct deals, or co-investments.
Who are the key executives at Zymo Research?
No named executives, principals, or investment professionals are publicly listed on the firm's website or otherwise disclosed in available sources. The firm does not present a leadership page or team directory.
Where does the underlying wealth come from?
Wealth origin is undisclosed. The firm presents itself as a private biotechnology company, and the founder's identity or background is not publicly available. No family name is associated.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: